Source: iQoncept / Shutterstock
BioAtla (NASDAQ:BCAB) has just unveiled its financial performance for the final quarter of 2023.
- Impressively, BioAtla posted earnings per share of -56 cents, surpassing the analyst consensus of -79 cents.
- Nevertheless, the company did not disclose any revenue figures for this quarter.
InvestorPlace Earnings is a pioneering initiative that taps into TradeSmith data to automatically cover quarterly earnings reports. Through InvestorPlace Earnings, investors can swiftly grasp key metrics such as earnings per share, revenue, and how a company measures up against analyst forecasts. These updates are produced without human involvement, enabling us to promptly deliver the latest financial information. If you identify any issues or inaccuracies, kindly reach out to us at [email protected].
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/bcab-stock-earnings-bioatla-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
